Tevogen Bio Announces 2026 Annual Meeting of Stockholders
TEVOGEN Tevogen Initiatives WARREN, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc.” or "Company”) (Nasdaq: TVGN) announced that its 2026 Annual Meeting of Stockholders…
Read the full articleYou might also wanna read
Emcure Pharma Schedules Q1 FY27 Board Meeting on August 6; Concall at 4 PM IST
Emcure Pharmaceuticals has scheduled its Q1 FY27 board meeting for August 6, 2026, to review its financial results, followed by an investor
Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here’s What It Means for the Stock.
A judge just saved Enbrel’s pricing. Tavneos heads to an FDA hearing on July 29. What happens to Amgen stock next?
Nuvation Bio Inc. Files Form 8-K with SEC Regarding Material Corporate Event
UNITED STATES
aTyr Pharma Aktie: November-2026-Frist für Ein-Dollar-Marke
Starke Kursgewinne treffen auf harten regulatorischen Druck. Bei aTyr Pharma entscheidet sich in den kommenden Monaten, ob das Biotech-Unter
Outlook Therapeutics Aktie: FDA-Entscheidung am 29. Juli 2026
Ein Biotech-Wert im Höhenflug: Die Aktie von Outlook Therapeutics schoss am Mittwoch um 14,73 Prozent nach oben. Der Grund liegt in einem na
Xeris Biopharma Holdings, Inc. Files Form 8-K with SEC (June 29, 2026)
UNITED STATES
Comments
Sign in to join the conversation.
No comments yet. Be the first.